Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid.

作者: E. Marie Lindholm , John K. Bielicki , Linda K. Curtiss , Edward M. Rubin , Trudy M. Forte

DOI: 10.1021/BI972888I

关键词:

摘要: Human apolipoprotein A-I (apoA-I) has an important role in the efflux of cholesterol from peripheral cells, first step reverse transport. Deletion amino acids Glu146-->Arg160 apoA-I (apoA-ISeattle) removes a large section lipid binding helix and is associated vivo with atherogenic lipoprotein profile characterized by deficiency high-density lipoproteins (HDL). In present study, we asked whether apoA-ISeattle had normal ability to recruit lipids cells form nascent (HDL) particles altered secondary structure affected lecithin:cholesterol acyltransferase (LCAT) activity. Wild-type expressed transfected Chinese hamster ovary formed HDL similar density distribution protein-to-lipid ratio. Phospholipid subclass demonstrated significant increase sphingomyelin phosphatidylethanolamine compared wild type. ApoA-ISeattle unique size wild-type HDL; (9-20 nm) predominated while there were virtually no small (7.5 particles. LCAT reactivity was impaired where esterification only half that complexes. The conformation on studied panel monoclonal antibodies (Mabs) specific for apoA-I. Mabs recognize putative activation site, residues 95-122, reactivity. As expected, recognized 141-164 unreactive because 146-160 deletion; addition, low Mab recognizes 220-242. data suggest and/or 220-242 partake cooperative interactions between helices may be maximal esterification.

参考文章(12)
C.L. Banka, D.J. Bonnet, A.S. Black, R.S. Smith, L.K. Curtiss, Localization of an apolipoprotein A-I epitope critical for activation of lecithin-cholesterol acyltransferase. Journal of Biological Chemistry. ,vol. 266, pp. 23886- 23892 ,(1991) , 10.1016/S0021-9258(18)54366-0
M Sorci-Thomas, M.W. Kearns, J.P. Lee, Apolipoprotein A-I domains involved in lecithin-cholesterol acyltransferase activation. Structure:function relationships. Journal of Biological Chemistry. ,vol. 268, pp. 21403- 21409 ,(1993) , 10.1016/S0021-9258(19)36938-8
C J Fielding, P E Fielding, Molecular physiology of reverse cholesterol transport. Journal of Lipid Research. ,vol. 36, pp. 211- 228 ,(1995) , 10.1016/S0022-2275(20)39898-9
G Franceschini, C R Sirtori, A Capurso, K H Weisgraber, R W Mahley, A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. Journal of Clinical Investigation. ,vol. 66, pp. 892- 900 ,(1980) , 10.1172/JCI109956
G M Anantharamaiah, Y V Venkatachalapathi, C G Brouillette, J P Segrest, Use of synthetic peptide analogues to localize lecithin:cholesterol acyltransferase activating domain in apolipoprotein A-I. Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 10, pp. 95- 105 ,(1990) , 10.1161/01.ATV.10.1.95
H Funke, A von Eckardstein, P H Pritchard, M Karas, J J Albers, G Assmann, A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities. Journal of Clinical Investigation. ,vol. 87, pp. 371- 376 ,(1991) , 10.1172/JCI114997